menu-hamburger-svgrepo-com

Can young children take antihistamines?

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Rupatadine is a second-generation antihistamine indicated for the treatment of AR and urticaria. The aim and strength of this study was to provide information regarding the safety and efficacy of rupatadine in very young children (two-five years) suffering from AR. There is very little published research on children diagnosed according with ARIA classification and treated with second-generation anti-H1 compounds. Most of the available paediatric literature with antihistamines are published with seasonal or perennial AR in older children (over six years old).  

Safety assessments were collected during the study including spontaneous adverse events, vital signs, and electrocardiogram (QTc interval). Additionally, evaluations of Total Five Symptoms Score (T5SS, including: nasal congestion; sneezing; rhinorrhoea; itchy nose, mouth, throat, and/or ears; and itchy, watery, and red eyes) were analysed. Symptoms were evaluated by parents/legal guardian before and after four weeks of rupatadine administration, dosed according to body weight. 

A total of 44 children received the study treatment. Only 15 adverse events were reported. All of them were of mild intensity and considered not related to the study treatment. 

From a maximum score value of 15, T5SS values at day 14 (6.35) and day 28 (5.42) were both statistically significant different (p<0.001) from the baseline T5SS value (mean 8.65), with a reduction of 26% and 37%, respectively. All individual symptoms, including nasal congestion, also showed a decrease from baseline at both 14 and 28 days. 

The percentage of improvement in symptoms after four weeks of treatment (37%) is close to a major pivotal trial using the same endpoint with a placebo-controlled design, and this similarity gives external validation of the present data in very young children. In addition, all symptoms improved individually, at least an average 20% of improvement, even for nasal congestion. The improvement obtained in T5SS after 28 days was somewhat higher than after 14 days (mean value 26%), showing that there was no tachyphylaxis. 

CONCLUSION 

This study showed that once-daily rupatadine oral solution was found to be safe and was correlated with an improvement of AR symptoms in young children (two-five years old) with a magnitude similar to that observed in older ones (6-11 years old).   

COST PER DOSE 

 

Suggested Articles

Suggested Clinical & CPD content

CPD: 1pt

Related articles

Welcome to Medical Academic​

Get the most out of Medical Academic by telling us your occupation. This helps us create more great content for you and the community.

idea

1000’s of Clinical and CPD content compiled by Key Opinion Leaders and our expert medical editors.

connection

Access to medical webinars and events

Group 193

Access medical journals from industry leaders and expert medical editorials.

Congratulations! Your account was successfully created.

Please check your email for an activation mail. Click the activation link to activate your account

Stay up to date

Search for anything across CPD, webinars and journals
idea

1000’s of Clinical and CPD content compiled by Key Opinion Leaders and our expert medical editors.

connection

Access to medical webinars and events

Group 193

Access medical journals from industry leaders and expert medical editorials.

Congratulations! You have successfully booked your seat.

All webinar details will be emailed to your email address.

Did you know, you can book future webinars with a single click if you register an account with Medical Academic.

Congratulations! Your account was successfully created.

Your webinar seat has been booked and all webinar details will be emailed to your registered email address

Why not register for Medical Academic while booking your seat for this webinar?

Future Medical Academic webinars can be booked with a single click, all with a Medical Academic account… and it’s FREE.

Book webinar & create your account

* (Required)

idea

1000’s of Clinical and CPD content compiled by Key Opinion Leaders and our expert medical editors.

connection

Access to medical webinars and events

Group 193

Access medical journals from industry leaders and expert medical editorials.

Congratulations! Your account was successfully created.

Thank you for registering. You can now log in to your account.

Create your account

* (Required)

Login with One Time Pin (OTP)

Enter your registered email address to receive an OTP

A verification code will be sent to your email address. Please ensure that admin@medicalacademic.co.za is on your safe sender list.

We've sent your OTP